Evidence map›Paper›PMID 21746806›Full record

ArticleMolecular cancer therapeutics2011

Synthetic triterpenoid cyano enone of methyl boswellate activates intrinsic, extrinsic, and endoplasmic reticulum stress cell death pathways in tumor cell lines.

Palaniyandi Ravanan, Renata Sano, Priti Talwar, Satoshi Ogasawara, Shu-ichi Matsuzawa, Michael Cuddy, Sanjay K Singh, G S R Subba Rao, Paturu Kondaiah, John C Reed

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Palaniyandi RavananSanford-Burnham Medical Research Institute, 10901 N Torrey Pines Road, La Jolla, CA 92037, USA.
Renata Sano
Priti Talwar
Satoshi Ogasawara
Shu-ichi Matsuzawa
Michael Cuddy
Sanjay K Singh
G S R Subba Rao
Paturu Kondaiah
John C Reed
Vellore Institute of Technology University · INIndian Institute of Science Bangalore · INSanford Burnham Prebys Medical Discovery Institute · US

Funding

Small Molecule Antagonists of IAPs Based on Mimicking SMACU19CA113318 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REED, JOHN C · 2005 to 2009
$5.7M
Virulence Mechanisms of Viral Bcl-2 HomologsR01AI091967 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MATSUZAWA, SHU-ICHI · 2011 to 2015
$2.4M
NCI NIH HHS P01-CA-113318NCI NIH HHS U19 CA113318NIAID NIH HHS R01 AI091967
6 · The paper itself

Abstract

We explored the effect of a novel synthetic triterpenoid compound cyano enone of methyl boswellates (CEMB) on various prostate cancer and glioma cancer cell lines. CEMB displayed concentration-dependent cytotoxic activity with submicromolar lethal dose 50% (LD(50)) values in 10 of 10 tumor cell lines tested. CEMB-induced cytotoxicity is accompanied by activation of downstream effector caspases (caspases 3 and 7) and by upstream initiator caspases involved in both the extrinsic (caspase 8) and intrinsic (caspase 9) apoptotic pathways. By using short interfering RNAs (siRNA), we show evidence that knockdown of caspase 8, DR4, Apaf-1, and Bid impairs CEMB-induced cell death. Similar to other proapoptotic synthetic triterpenoid compounds, CEMB-induced apoptosis involved endoplasmic reticulum stress, as shown by partial rescue of tumor cells by siRNA-mediated knockdown of expression of genes involved in the unfolded protein response such as IRE1α, PERK, and ATF6. Altogether, our results suggest that CEMB stimulates several apoptotic pathways in cancer cells, suggesting that this compound should be evaluated further as a potential agent for cancer therapy.

Indexed as

Antineoplastic AgentsApoptosisApoptotic Protease-Activating Factor 1BH3 Interacting Domain Death Agonist ProteinCaspasesCell DeathCell Line, TumorCell ProliferationEndoplasmic Reticulum StressEnzyme ActivationHumansNeoplasmsOleanolic AcidReceptors, TNF-Related Apoptosis-Inducing LigandSignal TransductionTriterpenesAntineoplastic AgentsApoptotic Protease-Activating Factor 1BH3 Interacting Domain Death Agonist ProteinCaspasesOleanolic AcidReceptors, TNF-Related Apoptosis-Inducing LigandTriterpenes

Identifiers

PMID21746806
PMCPMC4174562
OpenAlexW2111444463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.